EMILIO
ESTEBAN GONZALEZ
Profesor Titular de Universidad
Novartis (Sweden)
Täby, SueciaPublikationen in Zusammenarbeit mit Forschern von Novartis (Sweden) (1)
2014
-
Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: An open-label, randomised phase 3 trial
The Lancet Oncology, Vol. 15, Núm. 3, pp. 286-296